Daclizumab Subcutaneous and Oxycodone ER
Determining the interaction of Daclizumab Subcutaneous and Oxycodone ER and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: daclizumab
Brand name: Zinbryta, Zenapax
Synonyms: Daclizumab
Generic Name: oxycodone
Brand name: Oxaydo, Oxycontin, Oxyfast, Roxicodone, Roxybond, Xtampza ER; oxycodone is also present in the following combination drugs: Combunox, Endocet, Endodan, Moxduo, Oxycodan, Percocet, Percodan, Primlev, Roxicet, Xartemis XR, and others, Oxycontin, Xtampza ER, Oxecta, OxyIR, Roxybond
Synonyms: Oxycodone, OxyCODONE
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Daclizumab Subcutaneous-Oxycodone Extended-Release Capsules
- Daclizumab Subcutaneous-Oxycodone Extended-Release Tablets
- Daclizumab Subcutaneous-Oxycodone Hydrochloride
- Daclizumab Subcutaneous-Oxycodone Immediate-Release Capsules
- Daclizumab Subcutaneous-Oxycodone Solution
- Daclizumab Subcutaneous-Oxycodone Solution Concentrate
- Oxycodone ER-Dacogen
- Oxycodone ER-Dacomitinib
- Oxycodone ER-Dactinomycin
- Oxycodone ER-Dactinomycin Injection
- Oxycodone ER-Dactinomycin Intravenous
- Oxycodone ER-Daklinza